MATINAS BIOPHARMA HOLDINGS, INC. Accumulated Other Comprehensive Income
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Accumulated Other Comprehensive Income of -$51.00 thousand as of 2024-06-30, per its 10-Q filed 2024-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-04-15
- 2024-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$51.00K.
- 2024-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$134.00K.
- 2023-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$221.00K.
- 2023-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$359.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2024-06-30 | -$51.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$134.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$221.00K 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$359.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | -$514.00K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | -$595.00K 10-Q · filed 2024-05-09 | |
| 2022-12-31 | -$824.00K 10-K · filed 2025-04-15 | |
| 2022-09-30 | -$935.00K 10-Q · filed 2023-11-08 | -$935.57K 10-Q · filed 2022-11-02 |
| 2022-06-30 | -$754.00K 10-Q · filed 2023-08-09 | -$754.42K 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$629.00K 10-Q · filed 2023-05-10 | -$629.17K 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$145.00K 10-K · filed 2024-03-27 | -$145.50K 10-K · filed 2022-03-08 |
| 2021-09-30 | -$1.59K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $51.00K 10-Q · filed 2022-08-11 | $51.24K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $136.41K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $228.00K 10-K · filed 2023-03-15 | $228.17K 10-K · filed 2021-03-29 |
| 2020-09-30 | $364.00K 10-Q · filed 2021-11-08 | $363.55K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $478.00K 10-Q · filed 2021-08-10 | $477.70K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $522.00K 10-Q · filed 2021-05-10 | $522.37K 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$1.00K 10-K/A · filed 2022-03-11 | -$880.00 10-K · filed 2020-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |